Session R.A. II

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$529,102.40
Insider Sells Quantity
6
Insider Sells Sum
$388,733.84

Insider Activity of Session R.A. II

The largest purchase of all time was on 2021-11-23 and amounted to 42518 shares of Taysha Gene Therapies, Inc. for $529,102.

The largest sale of all time was on 2023-06-20 and amounted to 295653 shares of Taysha Gene Therapies, Inc. for $210,209.

Biography of Session R.A. II

No biography is available at this moment.

2023-07-13SaleTaysha Gene Therapies, Inc.
TSHA
10 percent owner
5,344
0.0084%
$0.70$3,741+232.86%
2023-07-12SaleTaysha Gene Therapies, Inc.
TSHA
10 percent owner
80,528
0.1263%
$0.71$57,030+224.23%
2023-06-23SaleTaysha Gene Therapies, Inc.
TSHA
10 percent owner
18,100
0.0305%
$0.70$12,735+242.42%
2023-06-22SaleTaysha Gene Therapies, Inc.
TSHA
10 percent owner
10,508
0.0163%
$0.70$7,384+214.94%
2023-06-21SaleTaysha Gene Therapies, Inc.
TSHA
10 percent owner
138,962
0.2204%
$0.70$97,635+221.43%
2023-06-20SaleTaysha Gene Therapies, Inc.
TSHA
10 percent owner
295,653
0.4778%
$0.71$210,209+223.74%
2021-11-23PurchaseTaysha Gene Therapies, Inc.
TSHA
President and CEO
42,518
0.1081%
$12.44$529,102-66.71%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.